Real-world evidences on adjuvant Pembrolizumab for renal cell carcinoma: results from the multicenter real-world ARON-1 study.
Saved in:
| Title: | Real-world evidences on adjuvant Pembrolizumab for renal cell carcinoma: results from the multicenter real-world ARON-1 study. |
|---|---|
| Authors: | Kopp RM; Clinical Oncology, Sociedad de Oncología y Hematología del Cesar, Valledupar, Colombia., Massari F; Medical Oncology, IRCCS Azienda Ospedaliero-Universitaria Di Bologna, Bologna, Italy. francesco.massari@aosp.bo.it.; Department of Medical and Surgical Sciences (DIMEC), University of Bologna, Bologna, Italy. francesco.massari@aosp.bo.it., Grande E; Department of Medical Oncology, MD Anderson Cancer Center Madrid, Madrid, Spain., Schieber TJ; Division of Medical Oncology, Department of Internal Medicine, University of Kansas Cancer Center, Kansas city, USA., Ürün Y; Department of Medical Oncology, Faculty of Medicine, Ankara University, Türkiye; Westwood, Ankara, KS, 06620, USA., Kopecký J; Department of Clinical Oncology and Radiotherapy, University Hospital Hradec Kralove, Hradec Kralove, Czechia., Molina-Cerrillo J; Department of Medical Oncology, Hospital Ramón y Cajal, Madrid, Spain., Basso U; Oncology 1 Unit, Department of Oncology, Istituto Oncologico Veneto IOV IRCCS, Padua, Italy., Kucharz J; Department of Uro-Oncology, Maria Sklodowska-Curie National Research Institute of Oncology Warsaw, Warsaw, Poland., Büttner T; Department of Urology, University Hospital Bonn (UKB), Bonn, Germany., Pichler R; Department of Urology, Medical University of Innsbruck, Innsbruck, Austria., Fiala O; Department of Oncology and Radiotherapeutics, Faculty of Medicine, University Hospital in Pilsen, Charles University, Pilsen, Czech Republic.; Biomedical Center, Faculty of Medicine in Pilsen, Charles University, Pilsen, Czech Republic., Myint ZW; Division of Medical Oncology, Department of Internal Medicine, Markey Cancer Center, University of Kentucky, Lexington, KY, USA., Galli L; Oncology Unit 2, University Hospital of Pisa, 56126, Pisa, Italy., Buchler T; Department of Oncology, Second Faculty of Medicine, Charles University and University Hospital Motol, V Uvalu 84, 150 06, Prague, Czech Republic., Rizzo M; Medical Oncology Unit, Azienda Ospedaliera Universitaria Consorziale Policlinico Di Bari, Bari, Italy., Bolek H; Department of Medical Oncology, Faculty of Medicine, Ankara University, Türkiye; Westwood, Ankara, KS, 06620, USA., Bourlon MT; Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico City, Mexico., Conteduca V; Unit of Medical Oncology and Biomolecular Therapy and C.R.E.A, T.E - Center for Research and Innovation Medicine, Department. of Medical and Surgical Sciences, University of Foggia, Policlinico Riuniti, Foggia, Italy., Pinto A; Servicio de Oncología, Hospital Universitario La Paz, Madrid, Spain., Rizzo A; S.S.D. C.O.R.O. Bed Management Presa in Carico, TDM, IRCCS Istituto Tumori ''Giovanni Paolo II'', Viale Orazio Flacco 65, 70124, Bari, Italy., Rosellini M; Department of Medical and Surgical Sciences (DIMEC), University of Bologna, Bologna, Italy., Roviello G; Department of Health Sciences, Section of Clinical Pharmacology and Oncology, University of Florence, Florence, Italy., Zgura A; Department of Oncology-Radiotherapy, Alexandru Trestioreanu Institute of Oncology, ''Carol Davila'' University of Medicine and Pharmacy, 020021, Bucharest, Romania., Mollica V; Medical Oncology, IRCCS Azienda Ospedaliero-Universitaria Di Bologna, Bologna, Italy., Partl A; Department of Urology, Medical University of Innsbruck, Innsbruck, Austria., Yildirim A; Department of Hematology and Oncology, Emory University School of Medicine, Atlanta, GA, USA., Akova U; Department of Hematology and Oncology, Emory University School of Medicine, Atlanta, GA, USA., Buti S; Medical Oncology Unit, University Hospital of Parma, Parma, Italy.; Department of Medicine and Surgery, University of Parma, Parma, Italy., Monteiro FSM; Oncology and Hematology Department, Hospital Sírio Libanês, Brasília, Brazil.; Latin American Cooperative Oncology Group - LACOG, Porto Alegre, Brazil., Soares A; Latin American Cooperative Oncology Group - LACOG, Porto Alegre, Brazil.; Oncology Unit, Hospital Israelita Albert Einstein, São Paulo, SP, Brazil., Porta C; Medical Oncology Unit, Azienda Ospedaliera Universitaria Consorziale Policlinico Di Bari, Bari, Italy.; Interdisciplinary Department of Medicine, University of Bari ''Aldo Moro'', Bari, Italy., Bilen MA; Department of Hematology and Oncology, Emory University School of Medicine, Atlanta, GA, USA.; Winship Cancer Institute of Emory University, Atlanta, GA, USA., Li H; Division of Medical Oncology, Department of Internal Medicine, University of Kansas Cancer Center, Kansas city, USA., Santoni M; Medical Oncology Unit, Macerata Hospital, Macerata, Italy. |
| Source: | Cancer immunology, immunotherapy : CII [Cancer Immunol Immunother] 2025 Nov 14; Vol. 74 (12), pp. 374. Date of Electronic Publication: 2025 Nov 14. |
| Publication Type: | Journal Article; Multicenter Study |
| Journal Info: | Publisher: Springer Verlag Country of Publication: Germany NLM ID: 8605732 Publication Model: Electronic Cited Medium: Internet ISSN: 1432-0851 (Electronic) Linking ISSN: 03407004 NLM ISO Abbreviation: Cancer Immunol Immunother Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
